BASF and Avantium together for biobased films and plastic bottles

image
Kurt Bock, Ceo of BASF

The German chemical giant BASF and the Dutch leading chemical technology company Avantium today announced that they have signed a letter of intent and entered into exclusive negotiations to establish a joint venture (JV) for the production and marketing of furandicarboxylic acid (FDCA) produced from renewable resources, as well as marketing of polyethylenefuranoate (PEF), based on this new chemical building block.

Continue reading

BASF and Genomatica expand license agreement for bio-based 1,4-butanediol (BDO)

Kurt Bock, Ceo of BASF
Kurt Bock, Ceo of BASF

BASF and Genomatica have expanded the scope of their license agreement for the production of 1,4-butanediol based on renewable feedstock (renewable BDO) using Genomatica’s patented process. The parties added certain countries in Southeast Asia to their initial agreement, which focused on North America.

Continue reading

We will have bio-based ski boots, skates and shoe soles

image
Headquarter of Basf in Ludwigshafen

“The bio-based PolyTHF 1000 is identical in quality to the petrochemical-based product.” To say it is Andrej Brejc, director Renewable Diols from BASF’s Intermediates division (sales to third parties of about 2.8 billion euro in 2014), which has made bio-based Polytetrahydrofuran 1000 (PolyTHF® 1000) available for the first time. The chemical company headquartered in Ludwigshafen is now providing this intermediate to selected partners for testing various applications in a large scale.

Continue reading

Basf exits bio-based acrylic acid partnership with Cargill and Novozymes

image
Kurt Bock, Ceo of Basf

Chemical giant Basf has decided to exit the current R&D collaboration with Novozymes and Cargill to develop a bio-based process for producing 3-hydroxypropionic (3-HP) and acrylic acid from renewable raw materials.

Continue reading

Bio-based acrylic acid: another milestone announced by BASF, Cargill and Novozymes

image
Kurt Bock, Ceo of Basf

BASF, Cargill and Novozymes announced the achievement of another milestone in their joint development of technologies to produce acrylic acid from renewable raw materials. The team has demonstrated the successful conversion of 3-hydroxypropionic acid (3-HP) to glacial acrylic acid and superabsorbent polymers. Moreover they have selected the process for further scale-up.

Continue reading

Succinity produces first commercial quantities of biobased succinic acid for the global market

Headquarter of Basf in Ludwigshafen
Headquarter of Basf in Ludwigshafen

Succinity GmbH, the joint venture between Corbion Purac, the worldwide market leader in lactic acid, lactic acid derivatives and lactides, and BASF, German chemical giant, for the production and commercialization of biobased succinic acid, has announced the successful start-up of its first commercial production facility.

Continue reading

BASF and Renmatix together for the production of industrial sugars based on lignocellulosic biomass

Headquarter of Basf in Ludwigshafen
Headquarter of Basf in Ludwigshafen

BASF and Renmatix will jointly scale up the Renmatix Plantrose process for the production of industrial sugars based on lignocellulosic biomass. The two companies signed a non-exclusive joint development agreement. The parties have agreed to key financial terms for future commercial licenses, which BASF can exercise at its discretion. The collaboration follows BASF’s $30 million investment in Renmatix in January 2012.

Continue reading

The $3 billion industrial enzyme industry now speaks German: BASF takes Verenium

Verenium Headquarter in San Diego, California
Verenium Headquarter in San Diego, California

BASF grows in biotechnology field and closes the gap on market leaders DuPont and Novozymes in the $3 billion industrial enzyme industry. The German world’s leading chemical company yesterday announced that it has successfully completed the previously announced tender offer to purchase all outstanding shares of common stock of Verenium Corporation, San Diego, California, for US$4.00 per share in cash. The tender offer expired at 9:00 a.m. Eastern Standard Time (USA) on October 31, 2013. As of the expiration of the tender offer, 11,337,044 Verenium shares were validly tendered and not withdrawn in the tender offer, representing approximately 71% of Verenium’s outstanding shares, according to the depositary for the tender offer. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be approximately US$62 million (approximately €48 million).

Continue reading

New turmoil in the $3 billion industrial enzyme industry: Basf agreed to buy Verenium

Kurt Bock, Ceo of Basf
Kurt Bock, Ceo of Basf

Basf, the world’s biggest chemical maker based in Ludwigshafen (Germany), agreed to buy Verenium Corp., a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, to pursue growth in biotechnology and close the gap on market leaders DuPont and Novozymes in the $3 billion industrial enzyme industry.

Continue reading

NPC of Saudi Arabia and Basf to collaborate in the field of algae technology

Riyad (Saudi Arabia) by night
Riyad (Saudi Arabia) by night

National Prawn Company (NPC) of Saudi Arabia and German firm Basf have agreed to collaborate in the field of algae technology. “The signed contract is marking once more the ability of Saudi Companies to be equal partners with World Class enterprises like Basf. It also shows that we are capable of offering solutions for domestic and global needs,” said NPC’s chairman Sulaiman Bin Abdul Aziz Al Rajhi.

Continue reading